Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Journal of Alzheimer s Disease2016Vol. 52(1), pp. 51–64
Citations Over TimeTop 10% of 2016 papers
Natalia Lelental, Sebastian Brandner, Olga Kofanova, Kaj Blennow, Henrik Zetterberg, Ulf Andréasson, Sebastiaan Engelborghs, Barbara Mroczko, Tomasz Gabryelewicz, Charlotte E. Teunissen, Brit Mollenhauer, Lucilla Parnetti, Davide Chiasserini, José Luís Molinuevo, Armand Perret‐Liaudet, Marcel M. Verbeek, Niels Andreasen, Frederic Brosseron, Justyna M.C. Bahl, Sanna-Kaisa Herukka, Lucrezia Hausner, Lutz Frölich, Anne Labonté, Judes Poirier, Anne-Marie Miller, Norbert Žilka, Branislav Kováčech, Andrea Urbani, Silvia Suardi, Catarina R. Oliveira, Inês Baldeiras, Bruno Dubois, Uroš Rot, Sylvain Lehmann, Anders Skinningsrud, Fay Betsou, Jens Wiltfang, Olymbia Gkatzima, Bengt Winblad, Michael Buchfelder, Johannes Kornhuber, Piotr Lewczuk
Abstract
Our results suggest that it is possible to replace self-made, CSF-based QC samples with large-scale volumes of QC materials prepared with artificial peptides and matrices. This would greatly facilitate intra- and inter-laboratory QC schedules for NDD measurements.
Related Papers
- → Investigation of the behavioral and neurochemical effects of monosodium glutamate on neonatal rats(2017)17 cited
- → The neurochemical sequelae of olfactory bulbectomy(1980)40 cited
- → Some Neurochemical Aspects of Convulsions(1971)38 cited
- → Basic Problems in Clinical Application of Microdialysis Technique(1995)
- → Neurochemical findings in the post-mortem schizophrenic brain(1978)